UNASSIGNED: Data from the cancer screening program between 2010 and 2016 were used to calculate higher rate (high-risk population/ participants recruited) and screening rate (participants received screening/ high-risk population).
UNASSIGNED: From 2010 to 2016, 1,637,429 residents were recruited in the program and filled the questionnaires, 350,646 (21.4%) for esophagus cancer, 273,715 (16.7%) for stomach cancer and 1,013,068 (61.9%) for liver cancer. 471,974 participants were assessed as high-risk population including 114,786 (24.3%) high risk for esophagus cancer, 161,809 (34.3%) high risk for stomach cancer and 195,379 (41.4%) high risk for liver cancer, respectively. 249,185 (52.8%) participants who were assessed as high risk received clinical screening. There were 64,710 (26.0%) for esophagus cancer screening, 71,365 (28.6%) for stomach cancer screening and 113,110 (45.4%) for liver cancer screening, respectively.
UNASSIGNED: Our findings will provide important references for designing effective population-based screening strategies to enhance the screening acceptance by health action plan in the future.
■来自2010年至2016年癌症筛查计划的数据用于计算更高的比率(高风险人群/招募的参与者)和筛查率(参与者接受筛查/高风险人群)。
■从2010年到2016年,该计划招募了1,637,429名居民,并填写了问卷,350,646(21.4%)用于食道癌,胃癌为273,715(16.7%),肝癌为1,013,068(61.9%)。471,974名参与者被评估为高危人群,包括114,786名(24.3%)食管癌高危人群。161,809(34.3%)胃癌高风险和195,379(41.4%)肝癌高风险,分别。249,185名(52.8%)被评估为高风险的参与者接受了临床筛查。有64,710(26.0%)进行食道癌筛查,71,365(28.6%)用于胃癌筛查,113,110(45.4%)用于肝癌筛查,分别。
■我们的发现将为设计有效的基于人群的筛查策略提供重要参考,以提高未来健康行动计划对筛查的接受度。